Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease
about
Biomarkers for detection of alcohol consumption in liver transplantationComparison of self-reported alcohol consumption to phosphatidylethanol measurement among HIV-infected patients initiating antiretroviral treatment in southwestern Uganda.Comparison of Traditional and Novel Self-Report Measures to an Alcohol Biomarker for Quantifying Alcohol Consumption Among HIV-Infected Adults in Sub-Saharan AfricaBiomolecules and Biomarkers Used in Diagnosis of Alcohol Drinking and in Monitoring Therapeutic Interventions.Identification of non-steroidal anti-inflammatory drug use disorder: A case report.Phosphatidylethanol Detects Moderate-to-Heavy Alcohol Use in Liver Transplant Recipients.Ethanol metabolites: their role in the assessment of alcohol intake.The Formation, Elimination, Interpretation, and Future Research Needs of Phosphatidylethanol for Research Studies and Clinical Practice.The Relationship Between Spirituality/Religiousness and Unhealthy Alcohol Use Among HIV-Infected Adults in Southwestern Uganda.Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease.High prevalence of unhealthy alcohol use and comparison of self-reported alcohol consumption to phosphatidylethanol among women engaged in sex work and their male clients in Cambodia.Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use.Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study.Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level.Quantification of phosphatidylethanol 16:0/18:1, 18:1/18:1, and 16:0/16:0 in venous blood and venous and capillary dried blood spots from patients in alcohol withdrawal and control volunteers.Do Subjective Alcohol Screening Tools Correlate with Biomarkers Among High-Risk Transgender Women and Men Who Have Sex with Men in Lima, Peru?Phosphatidylethanol (PEth) Levels among Incarcerated Women: The Influence of Pre-incarceration Alcohol Consumption and Length of Abstinence.Alcohol and Mortality: Combining Self-Reported (AUDIT-C) and Biomarker Detected (PEth) Alcohol Measures Among HIV Infected and Uninfected.High Throughput UPLC®-MSMS Method for the Analysis of Phosphatidylethanol (PEth) 16:0/18:1, a Specific Biomarker for Alcohol Consumption, in Whole Blood.Applications and Challenges for the Use of Phosphatidylethanol Testing in Liver Disease Patients (Mini Review).Alcohol sensors and their potential for improving clinical care.Alcoholic hepatitis: Continued drinking and the mourning after.Alcohol Biomarkers in Clinical and Forensic Contexts.Use of alcohol biomarkers to identify alcohol misuse in organ donors
P2860
Q26748593-385BC2BD-BDBB-4BAF-9105-D85C90C6FCF2Q34599554-439CC006-F732-41F9-BAC2-515838416577Q35889366-BEBCBA37-8BD8-4B40-9253-06321D353FCBQ36139051-EE917D80-22F6-4708-8D5A-048AE8CEA9A7Q36284813-0130BAB2-2577-468C-A552-393581428EC5Q38402669-0AE4A522-3713-403C-8DDD-7ED7D6E5D4D8Q38581962-DA1BFB2C-58E7-4EFB-B68C-C178803B323CQ38809369-AF8AD331-E750-4B31-B7EB-3DA2264FF8EEQ38850117-72E85503-B619-43E6-B834-C0A7DF8163BEQ39080886-647292A0-76B9-4CCD-AAD8-6328D2CCA398Q39717529-999B70F0-5306-4349-BE0B-249B51C6EF13Q40237305-7C798130-86F4-483D-8B63-C78544144F70Q40291497-2E7248B3-4802-49BE-AE98-1CBD2D2EB3B2Q40391238-91AD4855-9C76-4F13-AE42-6D101F119363Q46635096-1397AEEC-BDCD-4956-8611-E4B9131B9C4AQ46687665-D94A173A-8264-42EF-A8A2-B504E9FC2865Q47242580-6A5D97A1-CA2B-4239-95BE-4A8DAB975B20Q47588185-CAEFBBB9-0013-4579-82B7-3A27AB152203Q47700413-EF758962-806F-4745-A7B1-BFC16B6D752BQ48272231-3CB6D078-2347-409A-B71A-12B69804192EQ52306229-63D4EA77-1099-4518-A18B-EE9D3D2988F3Q53580504-4545DB26-27DA-48D3-9298-C2050F030395Q55098054-9F564531-2CDF-45C9-887A-ED5362BDC53CQ57497866-4BEE887D-D15C-4BA8-B28A-FE1C2DCAC2D4
P2860
Validation of blood phosphatidylethanol as an alcohol consumption biomarker in patients with chronic liver disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Validation of blood phosphatid ...... nts with chronic liver disease
@ast
Validation of blood phosphatid ...... nts with chronic liver disease
@en
type
label
Validation of blood phosphatid ...... nts with chronic liver disease
@ast
Validation of blood phosphatid ...... nts with chronic liver disease
@en
prefLabel
Validation of blood phosphatid ...... nts with chronic liver disease
@ast
Validation of blood phosphatid ...... nts with chronic liver disease
@en
P2093
P2860
P356
P1476
Validation of blood phosphatid ...... nts with chronic liver disease
@en
P2093
Adrian Reuben
David G Koch
Ira R Willner
Raymond F Anton
Scott H Stewart
P2860
P304
P356
10.1111/ACER.12442
P577
2014-05-21T00:00:00Z